Neros Technologies | $75,000,000 | (Nov 11, 2025)
Spectral Compute | $6,000,000 | (Nov 11, 2025)
TRIP | $40,000,000 | (Nov 11, 2025)
Certified by Founder
Lodge
Tenvie Therapeutics
start up
United States
- South San Francisco, California
- 09/01/2025
- Unknown
- $200,000,000
Tenvie is a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases. The company’s foundation is purpose-built with a diverse portfolio of small molecules and a proven team of CNS drug developers to rapidly deliver multiple clinical assets. Tenvie is advancing a pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases. Its portfolio of wholly owned, highly brain-penetrant, and precision-designed peripherally restricted small molecules address three key drivers of disease: resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function.
- Industry Biotechnology Research
- Website https://tenvie.com/
- LinkedIn https://www.linkedin.com/company/tenvie-therapeutics/
CampusKnot | $1,100,000 | (Nov 11, 2025)
Uare.ai | $10,300,000 | (Nov 11, 2025)
BITE Data | $2,500,000 | (Nov 11, 2025)
EVE(1) | $2,000,000 | (Nov 11, 2025)
Upward Financial | $8,000,000 | (Nov 11, 2025)
IDL (International Dance League) | $7,000,000 | (Nov 11, 2025)
Fastbreak AI | $40,000,000 | (Nov 11, 2025)
The Beans | $5,400,000 | (Nov 11, 2025)
NextSense, Inc | $16,000,000 | (Nov 11, 2025)